Benling Y. Xu
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Endogenous glucocorticoids and glucocorticoid receptor signaling: Dual regulators of PD-1/PD-L1 immunotherapy efficacy in the tumor microenvironment.
Journal: Chinese medical journal
Published: May 25, 2025
The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis.
Journal: Scientific reports
Published: February 27, 2025
Corrigendum to "CD69+ Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma" [Mol. Immunol. 172 (2024) 76-84].
Journal: Molecular immunology
Published: October 29, 2024
Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.
Journal: BMC cancer
Published: August 29, 2024
Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors.
Journal: Journal of leukocyte biology
Published: August 12, 2024
Transient-resting culture after activation enhances the generation of CD8+ stem cell-like memory T cells from peripheral blood mononuclear cells.
Journal: Translational oncology
Published: June 02, 2024
Role of COL5A1 in lung squamous cell Carcinoma: Prognostic Implications and therapeutic potential.
Journal: International immunopharmacology
Published: May 24, 2024
Pretreatment CD8 + PD-1 + to CD4 + PD-1 + ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors.
Journal: Melanoma research
Published: April 22, 2024
Subclone from CT26 resistant to anti-PD-1 therapy associated with increased expression of genes related to glucocorticoids.
Journal: Translational oncology
Published: March 08, 2024
CD69+ Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma.
Journal: Molecular immunology
Published: March 06, 2024
Expressions of CXCR3 and PD-1 on T cells and their clinical relevance in colorectal cancer.
Journal: International immunopharmacology
Published: January 06, 2024
The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer.
Journal: Cancer biology & medicine
Published: December 26, 2023
Last Updated: 09/26/2026